Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models

Cancer Letters

Volumn 248, Issue 1, 2007, Pages 47-57

  Osaki, Tomohiro ^a   Takagi, Satoshi ^a   Hoshino, Yuki ^a   Okumura, Masahiro ^a   Fujinaga, Toru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Benzoporphyrin derivative monoacid ring A; Photodynamic therapy; Power Doppler ultrasound

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIODE LASER; DOPPLER ECHOGRAPHY; FEMALE; HISTOLOGY; IRRADIATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; TUMOR; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR MODEL; TUMOR RECURRENCE; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD FLOW VELOCITY; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LASER-DOPPLER FLOWMETRY; MICE; MICE, INBRED C3H; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; PORPHYRINS; TIME FACTORS; TUMOR BURDEN;

MURINAE;

EID: 33847309907     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.05.021     Document Type: Article

References (35)

1. Konan Y.N., Gurny R., and Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 66 (2002) 89-106
2. Vrouenraets M.B., Visser G.W., Snow G.B., and van Dongen G.A. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res. 23 (2003) 505-522
3. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
4. Sharman W.M., Allen C.M., and van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4 (1999) 505-517
5. Kurohane K., Tominaga A., Sato K., North J.R., Namba Y., and Oku N. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett. 167 (2001) 49-56
6. Fingar V.H., Kik P.K., Haydon P.S., Cerrito P.B., Tseng M., Abang E., and Wieman T.J. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br. J. Cancer 79 (1999) 1702-1708
7. Shimizu K., and Oku N. Cancer anti-angiogenic therapy. Biol. Pharm. Bull. 27 (2004) 599-605
8. Foster T.H., Murant R.S., Bryant R.G., Knox R.S., Gibson S.L., and Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126 (1991) 296-303
9. Fingar V.H., Wieman T.J., Wiehle S.A., and Cerrito P.B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52 (1992) 4914-4921
10. van Geel I.P., Oppelaar H., Rijken P.F., Bernsen H.J., Hagemeier N.E., van der Kogel A.J., Hodgkiss R.J., and Stewart F.A. Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br. J. Cancer 73 (1996) 288-293
11. Sitnik T.M., Hampton J.A., and Henderson B.W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer 77 (1998) 1386-1394
12. Donnelly E.F., Geng L., Wojcicki W.E., Fleischer A.C., and Hallahan D.E. Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 219 (2001) 166-170
13. Vavere A.L., and Lewis J.S. Imaging the effects of anti-angiogenic treatments. Q. J. Nucl. Med. 47 (2003) 163-170
14. Ratcliffe P.J., O'Rourke J.F., Maxwell P.H., and Pugh C.W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 201 (1998) 1153-1162
15. Ferrario A., von Tiehl K.F., Rucker N., Schwarz M.A., Gill P.S., and Gomer C.J. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60 (2000) 4066-4069
16. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90 (1993) 4304-4308
17. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16 (1996) 4604-4613
18. Kaneko T., LePage G.A., and Shnitka T.K. KLN205 - a murine lung carcinoma cell line. In Vitro 16 (1980) 884-892
19. Asai T., Ueda T., Itoh K., Yoshioka K., Aoki Y., Mori S., and Yoshikawa H. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int. J. Cancer 76 (1998) 418-422
20. Gee M.S., Saunders H.M., Lee J.C., Sanzo J.F., Jenkins W.T., Evans S.M., Trinchieri G., Sehgal C.M., Feldman M.D., and Lee W.M. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res. 61 (2001) 2974-2982
21. Denis F., Bougnoux P., de Poncheville L., Prat M., Catroux R., and Tranquart F. In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours. Ultrasound Med. Biol. 28 (2002) 431-437
22. Denis F., Colas S., Chami L., Louisot P., Le Floch O., Tranquart F., and Bougnoux P. Changes in tumor vascularization after irradiation, anthracyclin, or antiangiogenic treatment in nitrosomethyl ureas-induced rat mammary tumors. Clin. Cancer Res. 9 (2003) 4546-4552
23. Goertz D.E., Christopher D.A., Yu J.L., Kerbel R.S., Burns P.N., and Foster F.S. High-frequency color flow imaging of the microcirculation. Ultrasound Med. Biol. 26 (2000) 63-71
24. Chen B., Pogue B.W., Goodwin I.A., O'Hara J.A., Wilmot C.M., Hutchins J.E., Hoopes P.J., and Hasan T. Blood flow dynamics after photodynamic therapy with Verteporfin in the RIF-1 tumor. Radiat. Res. 160 (2003) 452-459
25. Chen B., Roskams T., and de Witte P.A. Antivascular tumor eradication by Hypericin-mediated photodynamic therapy. Photochem. Photobiol. 76 (2002) 509-513
26. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 7987-7992
27. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiag. Photodynam. Ther. 1 (2004) 279-293
28. Axelson H., Fredlund E., Ovenberger M., Landberg G., and Pahlman S. Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin. Cell Dev. Biol. 16 (2005) 554-563
29. Palayoor S.T., Tofilon P.J., and Coleman C.N. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1α and HIF-2α in prostate cancer cells. Clin. Cancer Res. 9 (2003) 3150-3157
30. Chen B., Roskams T., Xu Y., Agostinis P., and de Witte P.A. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Int. J. Cancer 98 (2002) 284-290
31. Chen B., Pogue B.W., Hoopes P.J., and Hasan T. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1216-1226
32. T. Osaki, S. Takagi, Y. Hoshino, M. Okumura, T. Fujinaga, Intracellular localization and concentration as well as photodynamic effects of benzoporphyrin derivative monoacid ring A in four types of rodent tumor cells, Cancer Lett. (in press).
33. Huang Z., Chen Q., Shakil A., Chen H., Beckers J., Shapiro H., and Hetzel F.W. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy. Photochem. Photobiol. 78 (2003) 496-502
34. Sheng C., Pogue B.W., Wang E., Hutchins J.E., and Hoopes P.J. Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors. Photochem. Photobiol. 79 (2004) 520-525
35. Dolmans D.E., Kadambi A., Hill J.S., Flores K.R., Gerber J.N., Walker J.P., Borel Rinkes I.H., Jain R.K., and Fukumura D. Targeting tumor vasculature and cancer cells in orthopedic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res. 62 (2002) 4289-4294